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 In this prospective observational comparative case series, we aimed to study the 
peripapillary capillary network with spectral9domain optical coherence tomography angiography 
(OCT9A; Spectralis OCT2, Heidelberg Engineering) in Leber hereditary optic neuropathy (LHON). 
  Twelve eyes of six individuals, of these three males (5 eyes) after clinical onset of visual 
impairment were imaged by OCT9A with scans centred on optic discs. Control group consisted of 6 
eyes with no visual impairment. 
 The three affected individuals lost vision 6 years (at age 22 years), 2 years and 3 months (at 
age 26 years) and 1 year and 2 months (at age 30 years) prior to OCT9A examination. All 5 affected 
eyes had alterations in density of the radial peripapillary microvascular network at the level of retinal 
nerve fibre layer, including an eye of a patient treated with idebenone that underwent almost full 
recovery (best corrected visual acuity 0.87). Interestingly, the other eye showed normal ocular findings 
14 months after onset. Results of OCT9A examination in this eye were unfortunately inconclusive due 
to a delineation error. At the level of the ganglion cell layer differences could be also noted, but only 
in two severely affected individuals. There were no differences between unaffected mutation carriers 
and control eyes. 
 OCT9A scans confirmed that the peripapillary microvascular network is highly 
abnormal in eyes manifesting vision loss due to LHON. These findings support the hypothesis that 
microangiopathy contributes to the development of vision loss in this mitochondrial disorder. 
 
!	 " Leber hereditary optic neuropathy – mitochondrial 9 optical coherence tomography 
angiography 9 peripapillary microcirculation 9 microangiopathy	
	 	































































Leber hereditary optic neuropathy (LHON, OMIM #535000) is a rare disorder caused by mutations in 
mitochondrial DNA. It is the one of the most common inherited optic neuropathy with a reported 
prevalence of 31,000950,000 (Spruijt et al. 2006; Puomila et al. 2007; Yu9Wai9Man et al. 2003; 
Gorman et al. 2015). The onset of symptoms occurs mainly in the second and third decade of life. 
Typically, there is a subacute loss of vision accompanied by optic disc hyperemia, pseudoedema, 
peripapillary blood vessel abnormalities such as telangiectasia and tortuosity, and swelling of the 
retinal nerve fibre layer (RNFL) (Meyerson et al. 2015, Hwang et al. 2017). As the disease progress to 
chronic atrophic phase, optic disc pallor develops reflecting the death of retinal ganglion cells (RGCs) 
(Mashima et al. 2003; Corajevic et al. 2017, Himori et al. 2017). 
Optical coherence tomography angiography (OCT9A) provides high9resolution images of retinal and 
peripapillary capillaries by non9invasive visualization of vascular flow via motion contrast (de Carlo et 
al. 2015). This novel technique has several advantages over fluorescein angiography which has been 
the gold standard to evaluate retinal circulation in LHON patients (Smith et al. 1973; Nikoskelainen et 
al. 1977; Chalmers & Schapira 1999). Apart from greater resolution, OCT9A visualizes vascular 
structures in an arbitrarily selected depth of retinal layers without the need to administer a contrast 
agent (Spaide et al. 2015, Kiyota et al. 2017). To date, OCT9A imaging has been shown only in six 
genetically confirmed cases with visual loss due to LHON (De Rojas et al. 2016; Gaier et al. 2016; 
Ghasemi Falavarjani et al. 2016; Takayama et al. 2017). 
The purpose of this study was to evaluate the radial peripapillary capillary network in a series of 
individuals affected by vision loss due to LHON and asymptomatic mitochondrial DNA (mtDNA) 
mutation carriers in comparison to control eyes, and thus to improve our understanding of the 
pathogenetic mechanisms involved in the disease development and to assess the utility of OCT9A in 
clinical management of individuals with pathogenic mtDNA mutations. 
 
	 	































































Six individuals (12 eyes) from four families, all confirmed carriers of one the three prevalent 
pathogenic LHON mtDNA mutations (Table 1) and 6 healthy control eyes of three unrelated 
individuals were enrolled into the study. 
All subjects underwent ocular examination including measurement of best corrected visual acuity 
(BCVA) using Early Treatment Diabetic Retinopathy Study charts and extrapolated into decimal 
values. Visual field was assessed using standard automated perimeter (M9700 Medmont International, 
Vermont, Australia). Axial length was measured by IOLMaster 500 (Carl Zeiss Meditec AG, Jena, 
Germany). The normal range, as established in younger adults, was taken as 23.60 ± 1.15 mm (Tsai et 
al. 1992). Next, we performed spectral9domain OCT (SD9OCT) (Spectralis, Heidelberg Engineering 
GmbH, Heidelberg, Germany) of the macula and peripapillary retinal nerve fibre layer (RNFL) 
thickness measurements by circular scans 3.593.6 mm in diameter around the optic disc. The normal 
range of global RNFL thickness was regarded as 97.41 ± 11.73 µm in children and 97.52 ± 9.83 µm in 
adults. Temporal quadrant normal values were considered as 90.44 ± 20.49 µm in children and 83.65 ± 
14.98 µm in adults (Chung et al. 2016). Colour vision was tested using Lanthony desaturated 15 hue 
test (more than one major crossing was considered as abnormal) (Shoji et al. 2009) and contrast 
sensitivity with Pelli9Robson charts (values <1.50 were regarded as abnormal) (Leat et al. 1999). 
OCT9A (Spectralis OCT2, Heidelberg Engineering GmbH, Heidelberg, Germany) was performed 
between February and April 2017 by one skilled technician (MM). The scans with a 3x3 mm field of 
view were centred on the optic disc. Images from several depths were compared between eyes. 





Basic demographic characteristics and clinical details of the study participants are provided in Table 1. 
Five individuals (1, 2, 496) harboured m.11778G>A in a homoplasmic state, individual 3 was 






























































homoplasmic for m.14484T>C (Table 1). Patient 2 is a brother of an unaffected carrier 5 and subject 4 
is a son of individual 6. 
The clinical course of LHON in individuals 1 and 2 was typical, with bilateral sequential visual loss 
resulting into RNFL thinning more pronounced in the temporal quadrant, visible optic disc pallor, 
visual field defects (Fig. 1A9D), decreased contrast sensitivity and colour vision deficiency (Table 1). 
Patient 3 experienced visual loss in the left eye at the age of 29 years and 3 months. 27 days after the 
onset BCVA was 0.032 with profound visual field loss (Fig. 2D), colour vision defects and contrast 
sensitivity decrease. Pseudoedema of the left optic disc was documented by SD9OCT (Fig. 2F9H). In 
the right eye clinical findings were normal with BCVA 1.0 and no decrease in contrast sensitivity or 
colour vision deficiency. A mild central visual field defect was detected, which was attributed to a 
learning curve (Figure 2C). LHON diagnosis was confirmed by molecular genetic testing and 
idebenone treatment (900 mg/day) started 27 days after the onset. The left eye recovered significantly 
and at the point of OCT9A examination, 14 months after disease manifestation, BCVA improved to 
0.87 and only few mild central visual field defects could be documented (Fig. 1F). Significant RNFL 
thinning confirmed atrophy of the left optic disc (Table 1, Fig. 1F). Examination of the right eye 
showed no pathology (Fig. 1E). Consistent with high myopia the axial length in this patient was 
bilaterally above the normal limits.  
Subjects 4 was 11 years old at the time of OCT9A examination. He tested positive for the presence of 
m.11778G>A after LHON manifestation in his younger brother in whom OCT9A imaging could not 
be reliably performed due to age. Neither he nor his parents noticed any decrease of BCVA at any 
point. Consistent with this his ocular examination was normal (Table 1, Fig. 1G, H). Individuals 5 and 
6, also carriers of m.11778G>A, had also completely normal ocular findings including RNFL 
measurements (Table 1, Fig. 1I9L).  
OCT9A demonstrated peripapillary capillary dropout at the level of RNFL, i.e. from the internal 
limiting membrane (ILM) to RNFL posterior boundary in all eyes with LHON manifestation (i.e. both 
eyes of individuals 1, 2 and the left eye of individual 3) (Fig. 1A9D, F). Because of problems with 
automatic peripapillary delineation of RNFL (without the possibility of manual correction) in the right 






























































eye of individual 3, we had to decentre the scan slightly temporally. Therefore, comparison with other 
scans was not reliable (Fig. 1E). 
At the level of ganglion cell layer (GCL) differences could be also noted but only in the two severely 
affected individuals 1 and 2 (Supplementary Fig. 1). No major abnormalities were observed in 
microvascularization between the inner and outer plexiform layer (Supplementary Fig. 1). In the left 
eye of individual 2 OCT9A imaging suggested possible capillary drop out in the deep vascular plexus, 
in contrast to the clinically more severely affected fellow eye. We have concluded that this is most 
likely to be an artefact as the vessel density in all quadrants appeared similar. Overall the vascular 
network, plotted from total retina (ILM to Bruch membrane) demonstrated differences between the 
affected eyes and normal controls with a reduction of capillary density corresponding to the disease 




OCT9A is a novel, safe and rapid method that offers dissection of optic disc vascular perfusion and 
thus may help to differentiate various types of optic nerve disorders. To the best of our knowledge, 
this is the first study evaluating capillary network by OCT9A in a series of individuals carrying 
mtDNA mutations causing LHON, including three affected subjects and three unaffected carriers. 
Previously the microvascular network visualized by OCT9A has been reported in six cases with 
manifest visual impairment due to LHON (De Rojas et al. 2016; Gaier et al. 2016; Ghasemi 
Falavarjani et al. 2016; Takayama et al. 2017). 
We have documented reduction in radial peripapillary microvascular network in all 5 affected eyes of 
three individuals. A reduction of the peripapillary microvascular network can also be observed in other 
chronic optic neuropathies. In the LHON patients reported herein in the chronic phase of the disease 
capillary dropout was restricted to the RNFL and RGC layer, which maybe an important factor in 
differential diagnosis in unsolved cases with optic atrophy, as for example in patients with multiple 
sclerosis alterations of both the superficial and deep vascular plexus have been reported (Feucht et al. 
2018). 






























































The limitations of the current study are that quantitative assessment of capillary densities could not be 
performed because of lack of available software. Also, due to the impossibility of performing the 
OCT9A repeatedly we cannot comment on artefacts and variability in between different examinations. 
There are several theories as to how mitochondrial dysfunction may influence blood flow, including a 
direct effect on endothelial cell and vascular smooth muscle viability (Chiong et al. 2014; Goveia et al. 
2014). Unfortunately, we were not able to image a patient in the acute phase of LHON due to the rarity 
of the condition. A previous study using OCT9A in a carrier of m.11778G>A with optic disc 
pseudoedema has however shown microangiopathy in the fellow, subclinical eye suggesting that 
OCT9A may serve as a useful ancillary diagnostic tool to support early diagnosis, thus maximizing the 
chance for successful therapeutic intervention (Gaier et al. 2016). Hence we believe that current 
evidence supports the hypothesis that microangiopathy contributes to the visual loss in LHON. 
Apart from OCT9A imaging we also document the disease course in an individual with unilateral 
LHON 14 months after the disease onset, which is a rare finding, described in the literature only in a 
few adult cases (Jacobson et al. 1998; Dandekar et al. 2002; Nagai et al. 2005; Sugisaka et al. 2007). 
Twenty9seven days after the disease manifestation, there was a significant increase of RNFL thickness 
in superior, inferior and nasal quadrants while in the temporal quadrant it was within the normal range. 
This is in line with most recent prospective observations (Hwang et al. 2017). 
In conclusion, OCT9A results confirm that optic neuropathy in LHON patients is associated with 
decreased microcirculation primarily in the RNFL and RGC layer. Studies with larger sample sizes are 
necessary to assess the clinical usefulness of OCT9A in individuals with pathogenic mutations in 
mtDNA in terms of disease onset prediction, differential diagnosis and recovery. Results of OCT9A 
imaging in LHON patients in this and previous studies raise the expectation that the method could be 
used in diagnosing and monitoring function and RGC apoptosis, and thus further aid the unravelling of 
the pathogenesis of mitochondrial disorders. 
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Optic head nerve description 
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